Global Liquid Biopsy Market 2018-2022
About Liquid Biopsy
Liquid biopsy is also called fluid biopsy or fluid phase biopsy. It is a simple and non-invasive test to detect genetic changes in the tumor through a simple blood or urine sample. The preference toward liquid biopsy is significantly increasing over traditional tissue biopsy due to its less invasive nature and growing focus on personalized medicine in oncology diagnosis and treatment.
Technavio’s analysts forecast the global liquid biopsy market to grow at a CAGR of 34.25% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global liquid biopsy market for 2018-2022. To calculate the market size, the report considers the revenue generated by the use of the liquid biopsy technologies including CTC and ctDNA and exosome and RNA.
The market is divided into the following segments based on geography:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook